Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022

SELL
$30.71 - $45.71 $767 - $1,142
-25 Closed
0 $0
Q3 2021

Oct 12, 2021

SELL
$40.26 - $57.37 $120 - $172
-3 Reduced 10.71%
25 $1,000
Q2 2020

Jul 23, 2020

BUY
$25.95 - $43.15 $259 - $431
10 Added 55.56%
28 $1,000
Q1 2020

Apr 30, 2020

BUY
$26.15 - $77.24 $470 - $1,390
18 New
18 $1,000
Q4 2019

Jan 31, 2020

SELL
$60.18 - $154.77 $782 - $2,012
-13 Closed
0 $0
Q1 2019

Apr 24, 2019

BUY
$89.33 - $163.65 $1,161 - $2,127
13 New
13 $2,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Tarbox Family Office, Inc. Portfolio

Follow Tarbox Family Office, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tarbox Family Office, Inc. with notifications on news.